Glyxambi — Empagliflozin 10 mg / 5 mg, 10 pcs, Boehringer Ingelheim
100% original product

Glyxambi (Empagliflozin + Linagliptin) 10 mg/5 mg

5054₴ 5933₴ -15%

Glyxambi (Empagliflozin 10 mg / Linagliptin 5 mg) is a premium fixed-dose combination therapy for Type 2 Diabetes.

Manufacturer: Boehringer Ingelheim (Germany). This medication combines two potent antidiabetic agents in a single pill to provide superior glycemic control compared to monotherapy.

Mechanism of Action ("Dual Pathway Control"):

  1. Empagliflozin (SGLT2 Inhibitor): Removes excess glucose from the body through urine by preventing the kidneys from reabsorbing it.
  2. Linagliptin (DPP-4 Inhibitor): Increases the levels of hormones that stimulate the pancreas to produce insulin after meals and signals the liver to produce less sugar.

✅ Key Benefit: Effective blood sugar reduction, potential weight loss, and cardiovascular benefits associated with Empagliflozin.

Indicated for adults with:

  • 🍬 Type 2 Diabetes Mellitus: As an adjunct to diet and exercise to improve glycemic control.
  • Suitable for patients inadequately controlled on Metformin or those already treated with Empagliflozin and Linagliptin separately.

Packaging: Film-coated tablets (10 mg / 5 mg).

⚠️ DOSAGE & ADMINISTRATION:

  • 💊 Standard Dose: One tablet taken once daily.
  • ⏰ Timing: Recommended to be taken in the morning, with or without food.
  • 💧 Hydration: Drink plenty of water throughout the day to prevent dehydration.
  • 💉 Type 1 Diabetes Mellitus.
  • Diabetic Ketoacidosis (DKA).
  • Severe renal impairment (eGFR < 30 mL/min).
  • Pregnancy and breastfeeding.

Specific side effects related to mechanism of action:

  • 🚻 Genital Infections: Yeast infections (Candida) in both men and women due to glycosuria (sugar in urine). Good hygiene is essential.
  • 💧 Dehydration: Increased urination and thirst.
  • 📉 Hypoglycemia: Low risk alone, but possible if combined with Insulin or Sulfonylureas.
  • Urinary Tract Infections (UTIs).

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 29.03.2026

Active ingredient
Empagliflozin Linagliptin
Manufacturer
Boehringer Ingelheim
Dosage 10 mg / 5 mg
Dosage form Tablets
Tablets per pack 10
100% original product
Delivery across Ukraine
Customer reviews

What Customers Say

No reviews yet

Your review can be the first!

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00